Labs / Assays & in vitro testing

Inaphaea BioLabs
Nottingham, United Kingdom · inaphaea.com
GLP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Inaphaea BioLabs is a translational contract research organisation based in MediCity, Nottingham, United Kingdom. It provides cell-based assay services for early drug discovery and pre-clinical development, with a focus on oncology and women’s health. The company works with pharma partners and other drug discovery teams on customised assay development and data analysis.
They take quote requests by email.
What they offer
Cancer Cell Assays
Validated and bespoke cancer cell assays to measure cytotoxicity, cell metabolism, apoptosis markers, cell death, cell count, and related drug response readouts.
Cell Population Analysis
Flow cytometry and FACS assay design and implementation for profiling cell cycle, viability, apoptosis, and protein expression in cell populations.
Cell Proliferation and Viability Assays
Assays for cell growth, survival, and death using metabolic, ATP, membrane integrity, nuclear staining, mitochondrial function, DNA synthesis, and high-content imaging readouts.
Immunoassays
Custom immunoassay development, qualification, and validation for measuring hormones, cytokines, cellular activity, and proliferation under stimulation conditions.
Biological Modelling and Advanced Statistical Analysis
Integration of generated data with Physiomics modelling capability for biological modelling and advanced data interpretation.
Pre-Formulation and Formulation Development
Formulation development support integrated with cell-based assays to confirm suitability of molecules and formulation bioactivity.
Enzyme Assays
Contract research services and assay kits for studying DNA-modifying enzyme activity, including screening, IC50 determination, mode of action studies, and custom protein production.
AI toxicity prediction
AI-based drug toxicity prediction service that provides machine-learning outputs interpreted by expert scientists.
In-Vitro Liver Cell Assays
Liver model technology for efficacy and toxicology screening using large-scale generation of hepatocyte-like cells (Opti-Heps).
Tissue Based Analysis
Tissue-based biomarker evaluation including histology, immunohistochemistry, multiplex immunofluorescence, multiplex in situ hybridisation, digital pathology, and image analysis.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, Recombinant protein
- Species and models
- human, patient-derived cells, cancer cell lines, chemo-resistance cancer cell lines, 3D spheroid models, 2D monolayers, PBMCs, T cells, B cells, NK cells, macrophages, Opti-Heps
- Assays and studies
- cytotoxicity, cell metabolism, apoptosis, cell proliferation, cell viability, chequerboard synergy, dose-response, IC50, IC90, cell cycle, FACS, flow cytometry, and 3 more
- Instruments and platforms
- flow cytometry, FACS, high-content imaging, automated liquid handling systems, RNAScope
- Scale and capacity
- large-scale generation of hepatocyte-like cells (Opti-Heps), 66 oncology disease indications
- Therapeutic areas
- oncology, women’s health, drug discovery, pre-clinical development, toxicology screening, efficacy screening
- Minimums and prices
- fixed pricing for standard, validated assays
- Type
- CRO
- Sites
- Nottingham, United Kingdom
- Quality
- GLP/GCP compliant (tissue based evaluation of biomarkers)
Similar labs. Aurigene Pharmaceutical Services, EyeCRO, MedChem Partners, Sai Life
Found in a contract services directory. Listing built from inaphaea.com. Work here? Claim this listing.